 |
| Figure 1: Organisms most frequently isolated from wound pathogens at Cheshire Hall Laboratory 2013 -2015, identified by |
|
| Figure 1: Organisms most frequently isolated from wound pathogens at Cheshire Hall Laboratory 2013 -2015, identified by |
 |
| Figure 2: Overall resistance rates of antibiotics tested against all pathogens isolated |
Antimicrobial Agents |
Acinetobacter spp. N=73 |
Enterobacter spp. N=62 |
E Coli N=122 |
Klebsiella spp. N=92 |
Proteus spp. |
Pseudomonas spp. N=204 |
|||||||
|
n |
%R |
n |
%R |
n |
%R |
n |
%R |
n |
%R |
n |
%R |
|
Augmentin (20/10ug) |
68 |
53.9 |
62 |
87.0 |
110 |
46.8 |
88 |
25.0 |
128 |
22.7 |
|
|
|
Ceftriaxone (30 ug) |
52 |
44.2 |
51 |
26.2 |
104 |
45.1 |
82 |
20.7 |
129 |
10.9 |
54 |
55.5 |
|
Ciprofloxacin (5 ug) |
71 |
11.3 |
62 |
2.9 |
115 |
56.5 |
88 |
15.9 |
132 |
5.3 |
188 |
18.6 |
|
Gentamicin (10 ug) |
72 |
18.0 |
62 |
7.7 |
116 |
36.2 |
90 |
12.2 |
130 |
4.6 |
190 |
22.1 |
|
Meropenem (10 ug) |
43 |
12.2 |
62 |
4.4 |
107 |
0.0 |
71 |
1.4 |
108 |
0.9 |
181 |
11.0 |
|
Bactrim (23.75/1.25 ug) |
49 |
24.6 |
58 |
17.2 |
117 |
68.2 |
77 |
45.5 |
118 |
32.2 |
|
|
|
Amikacin (30 ug) |
|
|
|
|
|
|
|
|
|
|
101 |
4.0 |
|
Tobramicin (10 ug) |
|
|
|
|
|
|
|
|
|
|
113 |
21.2 |
|
Piperacillin (100 ug) |
|
|
|
|
|
|
|
|
|
|
128 |
1.6 |
|
Ceftazidime (30 ug) |
|
|
|
|
|
|
|
|
|
|
103 |
5.8 |
|
Key:N= Number of isolates; n=number of isolated tested against individual antimicrobial; %R= resistance rates (percent of isolates resistant to antimicrobial agent) |
|||||||||||||
Antimicrobial Agents |
NON MRSA N=328 |
MRSA N=138 |
CNS N=69 |
Enterococcus spp. N=131 |
S. Angalactiae N=103 |
||||||||
|
n |
%R |
n |
%R |
n |
%R |
n |
%R |
n |
%R |
|||
Augmentin (20/10ug) |
323 |
0.9 |
|
|
65 |
4.0 |
129 |
7.8 |
101 |
6.1 |
|||
Bactrim (23.75/1.25 ug) |
316 |
6.0 |
105 |
6.7 |
65 |
50.8 |
99 |
21.2 |
88 |
87.5 |
|||
Erythromycin (15 ug) |
321 |
16.2 |
120 |
83.3 |
65 |
56.9 |
115 |
63.5 |
95 |
16.8 |
|||
Clindamycin (2 ug) |
324 |
2.2 |
135 |
20.7 |
62 |
32.3 |
121 |
95.9 |
96 |
11.5 |
|||
Pencillin (10lU/IE/Ul) |
|
|
|
|
|
|
77 |
9.1 |
96 |
1.0 |
|||
Vancomycin (30 ug) |
260 |
0.4 |
120 |
0.0 |
107 |
3.7 |
101 |
0.0 |
66 |
0.0 |
|||
Rifampin (5 ug) |
|
|
68 |
1.5 |
|
|
|
|
|
|
|||
Key: CNS=-Coagulase negative staphulococcus; Non-MRSA= non methicillin-resistant S.aureus; MRSA= methicillin-resistant S.aureus; N= Number of isolates; n=number of isolated tested against individual antimicrobial; %R= resistance rates (percent of isolates resistant to antimicrobial agent). |
|||||||||||||